食品与发酵工业 >

2024 , Vol. 50 >Issue 17: 75 - 81

DOI: https://doi.org/10.13995/j.cnki.11-1802/ts.037264

研究报告

降解苯丙氨酸的工程益生菌构建及其喂养苯丙酮尿症小鼠的效果分析

  • 马欣 ,
  • 付加芳 ,
  • 林赓 ,
  • 张佩佩 ,
  • 曹广祥
展开
  • 1(山东第一医科大学(山东省医学科学院) 生物医学科学学院(省医药生物技术研究中心),山东 济南,250117)
    2(国家卫健委医药生物技术重点实验室(山东省医学科学院),山东 济南,250117)
    3(山东省罕少见病重点实验室,山东 济南,250117)
第一作者：硕士研究生(曹广祥研究员为通信作者,E-mail:caoguangxiang@sdfmu.edu.cn)

收稿日期: 2023-09-05

  修回日期: 2023-10-08

  网络出版日期: 2024-10-10

基金资助

山东第一医科大学青年培育基金项目(202201-004);山东省重点研发计划项目(2021ZDSYS27)

收起

Construction of engineered probiotic for degrading phenylalanine and analysis of its effect on feeding phenylketonuria mice

  • MA Xin ,
  • FU Jiafang ,
  • LIN Geng ,
  • ZHANG Peipei ,
  • CAO Guangxiang
Expand
  • 1(Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China)
    2(NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences), Jinan 250117, China)
    3(Key Lab for Rare & Uncommon Diseases of Shandong Province, Jinan 250117, China)

Received date: 2023-09-05

  Revised date: 2023-10-08

  Online published: 2024-10-10

Fold

摘要

苯丙酮尿症(phenylketonuria, PKU)是一种常染色体隐性遗传病,低蛋白饮食是目前临床治疗的主要方法,而采用工程益生菌治疗尚处于研发阶段。为了探究工程益生菌对PKU的治疗效果,该研究基于大肠埃希菌Nissle 1917(EcN)菌株,构建了一株表达苯丙氨酸裂解酶的工程益生菌EcN-PAL。通过λ-Red同源重组系统在EcN中导入经优化设计的苯丙氨酸裂解酶基因,并通过体外降解实验和小鼠喂养实验验证其功能性。实验结果表明,工程益生菌EcN-PAL成功表达苯丙氨酸裂解酶,并且可降解苯丙氨酸和有效降低PKU小鼠的血液苯丙氨酸浓度。该研究成功构建的工程益生菌EcN-PAL对苯丙氨酸有良好的降解效果,动物实验证实可有效治疗PKU小鼠,为用于PKU患者的益生菌治疗奠定了基础。

关键词： 苯丙酮尿症; λ-Red同源重组系统; 工程益生菌; 苯丙氨酸降解; 苯丙酮尿症小鼠

本文引用格式

马欣 , 付加芳 , 林赓 , 张佩佩 , 曹广祥 . 降解苯丙氨酸的工程益生菌构建及其喂养苯丙酮尿症小鼠的效果分析[J]. 食品与发酵工业, 2024 , 50(17) : 75 -81 . DOI: 10.13995/j.cnki.11-1802/ts.037264

Abstract

Phenylketonuria (PKU) is an autosomal recessive disease.A low-protein diet is the main treatment for PKU, and engineered probiotic is still in the stage of research and development.To explore the therapeutic effect of engineered probiotic on PKU, an engineered probiotic strain EcN-PAL expressing phenylalanine lyase was constructed based on Escherichia coli Nissle 1917 (EcN).The optimized codons of phenylalanine lyase gene was integrated into the genome of EcN by using the λ-Red homologous recombination system, and its function was verified by in vitro degradation experiment and mouse feeding experiment.Results showed that the phenylalanine lyase was successfully expressed in EcN-PAL, and the phenylalanine can be effectively degradated by EcN-PAL in vitro.The blood phenylalanine concentration in PKU mice showed a significant decrease when the mice was treated with EcN-PAL.The engineered probiotic E.coli EcN-PAL exhibited good ability to degrade phenylalanine, and could effectively treat PKU mice, laying a foundation for probiotic therapy in patients with PKU.

Key words： phenylketonuria; λ-Red homologous recombination system; engineered probiotic; phenylalanine degradation; PKU mouse model

参考文献

[1] FLYDAL M I, MARTINEZ A.Phenylalanine hydroxylase:function, structure, and regulation[J].IUBMB Life, 2013, 65(4):341-349.
[2] ANIKSTER Y, HAACK T B, VILBOUX T, et al.Biallelic mutations in DNAJC12 cause hyperphenylalaninemia, dystonia, and intellectual disability[J].The American Journal of Human Genetics, 2017, 100(2):257-266.
[3] BLAU N, VAN SPRONSEN F J, LEVY H L.Phenylketonuria[J].The Lancet, 2010, 376(9750):1417-1427.
[4] ZOU C W, CHEN Y, LI H Y, et al.Engineered bacteria EcN-MT alleviate liver injury in cadmium-exposed mice via its probiotics characteristics and expressing of metallothionein[J].Frontiers in Pharmacology, 2022, 13:857869.
[5] LEVENTHAL D S, SOKOLOVSKA A, LI N, et al.Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity[J].Nature Communications, 2020, 11(1):2739.
[6] JIANG Y, SUN B B, QIAN F H, et al.Expression of phenylalanine ammonia lyase as an intracellularly free and extracellularly cell surface-immobilized enzyme on a gut microbe as a live biotherapeutic for phenylketonuria[J].Science China Life Sciences, 2023, 66(1):127-136.
[7] ENNS G M, KOCH R, BRUMM V, et al.Suboptimal outcomes in patients with PKU treated early with diet alone:Revisiting the evidence[J].Molecular Genetics and Metabolism, 2010, 101(2-3):99-109.
[8] SCALDAFERRI F, GERARDI V, MANGIOLA F, et al.Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients:An update[J].World Journal of Gastroenterology, 2016, 22(24):5505.
[9] YAN X, LIU X Y, ZHANG D, et al.Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis[J].Cellular & Molecular Immunology, 2021, 18(10):2344-2357.
[10] KURTZ C, DENNEY W S, BLANKSTEIN L, et al.Translational development of microbiome-based therapeutics:Kinetics of E.coli Nissle and engineered strains in humans and nonhuman primates[J].Clinical and Translational Science, 2018, 11(2):200-207.
[11] SHAKIBA M, SANEIFARD H, ALAEI M R, et al.Clinical and paraclinical characteristics of non-classic phenylketonuria[J].Iranian Journal of Child Neurology, 2021, 15(3):131-138.
[12] NARDECCHIA F, MANTI F, DE LEO S, et al.Clinical characterization of tremor in patients with phenylketonuria[J].Molecular Genetics and Metabolism, 2019, 128(1-2):53-56.
[13] HODGINS D S.Yeast phenylalanine ammonia-lyase purification, properties, and the identification of catalytically essential dehydroalanine[J].Journal of Biological Chemistry, 1971, 246(9):2977-2985.
[14] ØRUM H, RASMUSSEN O F.Expression in E.coli of the gene encoding phenylalanine ammonia-lyase from Rhodosporidium toruloides[J].Applied Microbiology and Biotechnology, 1992, 36(6):745-748.
[15] GILBERT H J, CLARKE I N, GIBSON R K, et al.Molecular cloning of the phenylalanine ammonia lyase gene from Rhodosporidium toruloides in Escherichia coli K-12[J].Journal of Bacteriology, 1985, 161(1):314-320.
[16] PI J, WOOKEY P J, PITTARD A J.Cloning and sequencing of the pheP gene, which encodes the phenylalanine-specific transport system of Escherichia coli[J].Journal of Bacteriology, 1991, 173(12):3622-3629.
[17] ISABELLA V M, HA B N, CASTILLO M J, et al.Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria[J].Nature Biotechnology, 2018, 36(9):857-864.
[18] CHARBONNEAU M R, DENNEY W S, HORVATH N G, et al.Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria[J].Communications Biology, 2021, 4(1):898.
[19] 张雪, 温廷益.Red重组系统用于大肠杆菌基因修饰研究进展[J].中国生物工程杂志, 2008, 28(12):89-93.
ZHANG X,WEN T Y.Advances of red recombination system in Escherichia coli gene modification[J].China Biotechnology, 2008, 28(12):89-93.
[20] CHANG T M, BOURGET L, LISTER C.A new theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme-artificial cells, as in removing phenylalanine in phenylketonuria[J].Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1995, 23(1):1-21.
[21] WILLIAMS J S, THOMAS M, CLARKE D J.The gene stlA encodes a phenylalanine ammonia-lyase that is involved in the production of a stilbene antibiotic in Photorhabdus luminescens TT01[J].Microbiology, 2005, 151(Pt 8):2543-2550.
[22] CHEREPANOV P P, WACKERNAGEL W.Gene disruption in Escherichia coli:TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant[J].Gene, 1995, 158(1):9-14.
[23] DATSENKO K A, WANNER B L.One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products[J].Proceedings of the National Academy of Sciences of the United States of America, 2000, 97(12):6640-6645.
[24] 文江平, 唐爱国.高效液相色谱法快速测定血清中的芳香族氨基酸[J].色谱, 2003, 21(2):154-157.
WEN J P, TANG A G.Rapid analysis of aromatic amino acids in serum by high performance liquid chromatography[J].Chinese Journal of Chromatography, 2003, 21(2):154-157.
[25] 王楠, 田晗, 张文晓, 等.两株具有潜在益生作用的人源链球菌的安全性评价[J].食品与发酵工业, 2021, 47(5):12-16.
WANG N, TIAN H, ZHANG W X, et al.Safety evaluation of two strains of human Streptococcus with potential probiotics[J].Food and Fermentation Industries, 2021, 47(5):12-16.
[26] 郑鹏, 田亚光, 黄贺.小鼠繁殖行为的观察与分析[J].黑龙江动物繁殖, 2013, 21(3):20-23.
ZHENG P, TIAN Y G, HUANG H.Observation and analysis of reproductive behavior of mice[J].Heilongjiang Journal of Animal Reproduction, 2013, 21(3):20-23.
[27] CRISTÓBAL-LUNA J M, CORREA-BASURTO J, MENDOZA-FIGUEROA H L, et al.Anti-epileptic activity, toxicity and teratogenicity in CD1 mice of a novel valproic acid arylamide derivative, N-(2-hydroxyphenyl)-2-propylpentanamide[J].Toxicology and Applied Pharmacology, 2020, 399:115033.
[28] YU X L, LIN C S, YU J, et al.Bioengineered Escherichia coli Nissle 1917 for tumour-targeting therapy[J].Microbial Biotechnology, 2020, 13(3):629-636.
Options
文章导航

/

〈 〉

技术支持：北京玛格泰克科技发展有限公司